DrugsNews.net

Drugs Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Neurobase.it

Search results for "Siponimod"

The FDA ( U.S. Food and Drug Administration ) has approved Mayzent ( Siponimod ) tablets to treat adults with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing- ...


The European Commission ( EC ) has approved Mayzent ( Siponimod ) for the treatment of adult patients with secondary progressive multiple sclerosis ( SPMS ) with active disease evidenced by relapses o ...